The goals of our study were to compare the immune response to different killed and modified live vaccines against PRRS virus and to monitor the antibody production and the cell mediated immunity both at the systemic and local level. In the experiment, we immunized four groups of piglets with two commercial inactivated (A1-Progressis, A2-Suivac) and two modified live vaccines (B3-Amervac, B4-Porcilis). Twenty-one days after the final vaccination, all piglets, including the control non-immunized group (C5), were i.n., infected with the Lelystad strain of PRRS virus. The serum antibody response (IgM and IgG) was the strongest in group A1 followed by two MLV (B3 and B4) groups. Locally, we demonstrated the highest level of IgG antibodies in bronchoalveolar lavages (BALF), and saliva in group A1, whereas low IgA antibody responses in BALF and feces were detected in all groups. We have found virus neutralization antibody at DPV 21 (days post vaccination) and higher levels in all groups including the control at DPI 21 (days post infection). Positive antigen specific cell-mediated response in lymphocyte transformation test (LTT) was observed in groups B3 and B4 at DPV 7 and in group B4 at DPV 21 and in all intervals after infection. The IFN-γ producing lymphocytes after antigen stimulation were found in CD4-CD8+ and CD4+CD8+ subsets of all immunized groups 7 days after infection. After infection, there were obvious differences in virus excretion. The virus was detected in all groups of piglets in serum, saliva, and occasionally in feces at DPI 3. Significantly lower virus load was found in groups A1 and B3 at DPI 21. Negative samples appeared at DPI 21 in B3 group in saliva. It can be concluded that antibodies after immunization and infection, and the virus after infection can be detected in all the compartments monitored. Immunization with inactivated vaccine A1-Progressis induces high levels of antibodies produced both systemically and locally. Immunization with MLV-vaccines (Amervac and Porcilis) produces sufficient antibody levels and also cell-mediated immunity. After infection virus secretion gradually decreases in group B3, indicating tendency to induce sterile immunity.

Department of Immunology Veterinary Research Institute Brno Czechia

Department of Virology Veterinary Research Institute Brno Czechia

Faculty of Veterinary Medicine University of Veterinary and Pharmaceutical Sciences Brno Czechia

Zobrazit více v PubMed

Stadejek T, Oleksiewicz MB, Potapchuk D, Podgorska K. Porcine reproductive and respiratory syndrome virus strains of exceptional diversity in Eastern Europe support the definition of new genetic subtypes. J Gen Virol. (2006) 87:1835–41. 10.1099/vir.0.81782-0 PubMed DOI

Stadejek T, Oleksiewicz MB, Potapchuk D, Scherbakov AV, Timina AM, Krabbe JS, et al. . Definition of subtypes in the European genotype of porcine reproductive and respiratory syndrome virus: nucleocapsid characteristics and geographical distribution in Europe. Arch.Virol. (2008) 153:1479–88. 10.1007/s00705-008-0146-2 PubMed DOI

Darwich L, Gimeno M, Sibila M, Diaz I, de la Torre E, Dotti S, et al. . Genetic and immunobiological diversities of porcine reproductive and respiratory syndrome genotype I strains. Vet Microbiol. (2011) 150:49–62. 10.1016/j.vetmic.2011.01.008 PubMed DOI

Mengeling WL, Lager KM, Vorwald AC, Koehler KJ. Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus. Vet Microbiol. (2003) 93:13–24. 10.1016/S0378-1135(02)00427-3 PubMed DOI

Park CH, Seo HW, Han K, Kang I, Chae CH. Evaluation of the efficacy of a new modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (Fostera PRRS) against heterologous PRRSV challenge. Vet Microbiol. (2014) 172:432–44. 10.1016/j.vetmic.2014.05.030 PubMed DOI

Geldhof MF, Vanhee M, Van Breedam W, Van Doorsselaere J, Karniychuk U, Nauwynck HJ. Comparison of the efficacy of autogenous inactivated porcine reproductive and respiratory syndrome virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges. BMC Vet Res. (2012) 8:182. 10.1186/1746-6148-8-182 PubMed DOI PMC

Choi K, Park CH, Jeong J, Chae CH. Comparison of protection provided by type 1 and 2 porcine reproductive and respiratory syndrome field viruses against homologous and heterologous challenge. Vet Microbiol. (2016) 1191:72–81. 10.1016/j.vetmic.2016.06.003 PubMed DOI

Correas I, Osorio FA, Stefen D, Pattnaik AK, Vu HLX. Cross efficacy of immune responses to porcine reproductive and respiratory syndrome virus infection. Vaccine. (2017) 35:782–8. 10.1016/j.vaccine.2016.12.040 PubMed DOI

Xiao S, Mo D, Wang Q, Jia JY, Qin LM, Yu XC, et al. . Aberrant host immune response induced by highly virulent PRRSV identified by digital gene expression tag profiling. BMC Genomics. (2010) 11:544. 10.1186/1471-2164-11-544 PubMed DOI PMC

Karniychuk U, Geldhof M, Vanhee M, Van Doorsselaere J, Saveleva TA, Nauwynck HJ. Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolate. BMC Vet Res. (2010) 6:30. 10.1186/1746-6148-6-30 PubMed DOI PMC

Han J, Zhou L, Ge X, Guo X, Yang H. Pathogenesis and control of the Chinese highly pathogenic porcine reproductive and respiratory syndrome virus. Vet Microbiol. (2017) 209:2017. 10.1016/j.vetmic.2017.02.020 PubMed DOI

Loving CL, Osorio FA, Murtough MP, Zuckermann FA. Innate and adaptive immunity against porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol. (2015) 167:1–14. 10.1016/j.vetimm.2015.07.003 PubMed DOI PMC

Duan X, Nauwynck HJ, Pensaert MB. Effects of origin and state of differentiation and activation of monocytes/macrophages on their susceptibility to porcine reproductive and respiratory syndrome virus (PRRSV). Arch Virol. (1997) 142:2483–97. 10.1007/s007050050256 PubMed DOI PMC

Allende R, Laegreid WW, Kutish GF, Galeota JA, Willis RW, Osorio FA. Porcine reproductive and respiratory syndrome virus: description of persistence in individual pigs upon experimental infection. J Virol. (2000) 80:3994–4004. 10.1128/jvi.74.22.10834-10837.2000 PubMed DOI PMC

Mateu E, Diaz I. The challenge of PRRS imunology. Vet J. (2008) 177:345–51. 10.1016/j.tvjl.2007.05.022 PubMed DOI PMC

Gomez-Laguna J, Salguero FJ, Pallares FJ, Carraso L. Immunopathogenesis of porcine reproductive and respiratory syndrome in the respiratory tract of pigs. Vet J. (2013) 195:148–55. 10.1016/j.tvjl.2012.11.012 PubMed DOI PMC

Lunney JK, Fang Y, Ladinig A, Chen N, Yanhua L, Rowland B, et al. . Porcine reproductive and respiratory syndrome virus (PRRSV): pathogenesis and interaction with the immune system. Annu Rev Anim Bosci. (2016) 4:129–54. 10.1146/annurev-animal-022114-111025 PubMed DOI

Renukaradhya GJ, Aleksejev K, Jung K, Fang Y, Saif LJ. Porcine reproductive and respiratory syndrome virus-induced immunosuppression exacerbates the inflammatory response to porcine respiratory coronavirus. Viral Immunol. (2010) 23:457–66. 10.1089/vim.2010.0051 PubMed DOI PMC

Van Reeth K, Labarque G, Nauwynck H, Pensaert M. Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: correlation with pathogenicity. Res Vet Sci. (1999) 67:47–52. 10.1053/rvsc.1998.0277 PubMed DOI PMC

Yoon IJ, Joo HS, Goyal SM, Molitor TW. A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera. J Vet Diagnost Invest. (1994) 6:289–92. 10.1177/104063879400600326 PubMed DOI

Johnsen CK, Botner A, Kastrup S, Lind P, Nielsen J. Cytokine mRNA profiles in bronchoalveolar cells of piglets experimentally infected with porcine reproductive and respiratory syndrome virus: association of sustained expression of IFN-γ and IL-10 after viral clearance. Viral Immunol. (2002) 15:549–56. 10.1089/088282402320914494 PubMed DOI

Suradhat S, Thanawoghuwech R, Poovoran Y. Upregulation of Il-10 gene expression in peripheral blood mononuclear cells by porcine reproductive and respiratory syndrome virus. J Gen Virol. (2003) 84:453–9. 10.1099/vir.0.18698-0 PubMed DOI

Diaz I, Darwich I, Pappatera G, Pujols J, Mateu E. Immune response of pigs after experimental infection with European strain of porcine reproductive and respiratory syndrome virus. J Gen Virol. (2005) 89:1943–51. 10.1099/vir.0.80959-0 PubMed DOI

Kavanova L, Prodelalova J, Nedbalcova K, Matiasovic J, Volf J, Faldyna M, et al. . Immune response of porcine alveolar macrophages to a concurrent infection with porcine reproductive and respiratory syndrome virus and Haemophilus parasuis in vitro. Vet Microbiol. (2015) 180:28–35. 10.1016/j.vetmic.2015.08.026 PubMed DOI

Kavanova L, Matiašková K, Levá L, Nedbalcová K, Matiašovic J, Faldyna M, et al. Current infection of monocyte-derived macrophages and with porcine reproductive and respiratory syndrome virus and Haemophilus parasuis: a role of IFNα in pathogenesis of co-infections. Vet Microbiol. (2018) 225:64–71. 10.1016/j.vetmic.2018.09.016 PubMed DOI

Kimman TJ, Cornelissen LA, Moormann RJ, Rebel JMJ, Stockhofe-Zurwieden N. Challenges for porcine reproductive and respiratory syndrome virus(PRRSV) vaccinology. Vaccine. (2009) 27:3704–18. 10.1016/j.vaccine.2009.04.022 PubMed DOI

Murtaugh MP, Genzow M. Immunological solutions for treatment and prevention of porcine reproductive and respiratory syndrome (PRRS). Vaccine. (2011) 29:8192–204. 10.1016/j.vaccine.2011.09.013 PubMed DOI

Renukaradhya GJ, Meng XJ, Calvert JG, Roof M, Lager KM. Inactivated and subunit vaccines against porcine reproductive and respiratory syndrome: current status and future direction. Vaccine. (2015) 33:4069–80. 10.1016/j.vaccine.2015.06.092 PubMed DOI

Renukaradhya GJ, Meng XJ, Calvert JG, Roof M, Lager KM. Live porcine reproductive and respiratory syndrome virus vaccines: current status and future direction. Vaccine. (2015) 33:3065–72. 10.1016/j.vaccine.2015.04.102 PubMed DOI

Diaz I, Gimeno M, Callen J, Pujols J, Lopez S, Charreyre C, et al. . Comparison of different vaccination schedules for sustaining immune response against porcine reproductive and respiratory syndrome virus. Vet J. (2013) 197:438–44. 10.1016/j.tvjl.2013.02.008 PubMed DOI

Bonckaert C, Van der Meulen K, Rodriguez-Bellara I, Pedrazuela Sanz R, Martinez MF, Nauwynck HJ. Modified-live PRRSV subtype 1 vaccine UNISTRAIN PRRS provides a partial clinical and virological protection upon challenge with East European subtype 3 PRRSV strain Lena. Porcine Health Manag. (2016) 2:12. 10.1186/s40813-016-0029-y PubMed DOI PMC

Kristensen CHS, Kvisgaard LK, Pawlowski M, Holmgaard Carlsen S, Hjulsager CK, Heegaard PMH, et al. Efficacy and safety of simultaneous vaccination with two modified live virus vaccine against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs. Vaccine. (2018) 36:227–36. 10.1016/j.vaccine.2017.11.059 PubMed DOI

Sun H, Workman A, Osorio FA, Steffen D, Vu HLX. Development of a broadly protective modified-live vaccine candidate against porcine reproductive and respiratory syndrome virus. Vaccine. (2018) 36:66–73. 10.1016/j.vaccine.2017.11.028 PubMed DOI

Linhares DCL, Johnson C, Morrison RB. Economic analysis of vaccination strategies for PRRS control. PloS ONE. (2015) 10:e0144265 10.1371/journal.pone.0144265 PubMed DOI PMC

Pileri E, Mateu E. Review on the transmission porcine reproductive and respiratory syndrome virus between pigs and farms and impact on vaccination. Vet Res. (2016) 47:108. 10.1186/s13567-016-0391-4 PubMed DOI PMC

Nathues H, Alarcon P, Rushton J, Jolie R, Fiebig K, Jimenez M, et al. . Cost of porcine reproductive and respiratory syndrome virus at farm level – an economic model. Prev Vet Med. (2017) 142:16–29. 10.1016/j.prevetmed.2017.04.006 PubMed DOI

Nechvatalova K, Knotigova P, Krejci J, Faldyna M, Gopfert E, Satran P, et al. Significance of different types and levels of antigen-specific immunity to Actinobacillus pleuropneumoniae infection in piglets. Vet Med Czech. (2005) 50:47–59. 10.17221/5596-VETMED DOI

Stepanova H, Pavlova B, Stromerova N, Matiasovic J, Kaevska M, Pavlik I, Faldyna M. Cell-mediated immune response in swine infected with Mycobacterium avium subsp. Avium Vet Immunol Immunopathol. (2011) 142:107–12. 10.1016/j.vetimm.2011.04.005 PubMed DOI

Zelnickova P, Faldyna M, Stepanova H, Ondracek J, Kovaru F. Intracellular cytokine detection by flow cytometry in pigs: fixation, permeabilization and cell surface staining. J Immunol Methods. (2007) 327:18–29. 10.1016/j.jim.2007.07.006 PubMed DOI

Zuckermann FA, Garcia EA, Luque ID, Christopher-Hennings J, Doster A, Brito M, et al. . Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters upon challenge. Vet Microbiol. (2007) 123:69–85. 10.1016/j.vetmic.2007.02.009 PubMed DOI

Kuiek AM, Ooi PT, Yong CK, Chi FN. Comparison of serum and oral fluid antibody responses after vaccination with modified live (MLV) porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in PRRS endemic farms. Trop Anim Health Prod. (2015) 47:1337–42. 10.1007/s11250-015-0868-6 PubMed DOI PMC

Rotolo ML, Gimenez-Lirola L, Ji J, Magtoto R, Henao-Diaz YA, Wang CH, et al. . Detection of porcine reproductive and respiratory syndrome virus (PRRSV)-specific IgM-IgA in oral fluid samples reveals PRRSV infection in the presence of maternal antibody. Vet Microbiol. (2018) 214:13–20. 10.1016/j.vetmic.2017.11.011 PubMed DOI

Woonwong Y, Kedkovid R, Arunorat J, Sirisereewan CH, Nedumpun T, Poonsuk K, et al. . Oral fluid samples used for PRRSV acclimatization program and sow performance monitoring in endemic PRRS-positive farms. Trop Anim Health Prod. (2018) 50:291–8. 10.1007/s11250-017-1428-z PubMed DOI

Sattler T, Pikalo J, Wodak E, Schmoll F. Ability of ELISAs to detect antibodies against porcine reproductive and respiratory syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge. BMC Vet Res. (2016) 12:259. 10.1186/s12917-016-0888-0 PubMed DOI PMC

Madapong A, Temeeya G, Sang-chuto K, Tripipat T, Navasakuljinda W, Boonsoongnern A, et al. Humoral immune response and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines. Arch Virol. (2017) 162:139–46. 10.1007/s00705-016-3084-4 PubMed DOI

Kroll J, Piontkowski M, Rathkjen PH, Orveillon FX, Kraft CH, Duran OG. Long duration of immunity against a type 1 heterologous PRRS virus challenge in pigs immunised with novel PRRS MLV vaccine: a randomised controlled study. Porcine Health Manag. (2018) 4:11. 10.1186/s40813-018-0087-4 PubMed DOI PMC

Hrazdilova K, Dadakova E, Brozova K, Modry D, Vodicka R, Celer V. New species of Torque Teno miniviruses infecting gorillas and chimpanzees. Virology. (2016) 487:207–14. 10.1016/j.virol.2015.10.016 PubMed DOI

Dadakova E, Brozova K, Piel AK, Steward FA, Modry D, Celer V, et al. . Adenovirus infection in savanna chimpanzees (Pan troglodytes schweinfurthii) in the Issa Valley, Tanzania. Arch Virol. (2018) 163:191–6. 10.1007/s00705-017-3576-x PubMed DOI

Stadler J, Naderer L, Beffort L, Ritzmann M, Fiebig K, Saalmüller A, et al. Safety and immune response after intradermal application of Porcilis PRRS in either neck or the perianal region. PloS ONE. (2018) 13:e0203560 10.1371/journal.pone.0203560 PubMed DOI PMC

Piras F, Bolard S, Laval F, Joisel F, Reynaud G, Charreyre C, et al. . Porcine reproductive and respiratory syndrome (PRRS) virus-specific Interferon-γ+ T-cell responses after PRRS virus infection or vaccination with inactivated PRRS vaccine. Virol Immunol. (2005) 18:381–9. 10.1089/vim.2005.18.381 PubMed DOI

Saalmuller A, Verner T, Fachinger V. T-helper cells from naive to commited. Vet Immunol Immunopathol. (2002) 87:137–45. 10.1016/S0165-2427(02)00045-4 PubMed DOI

Chung CHJ, Cho SH, Grimm AL, Ajithdoss D, Rzepka J, Chung G, et al. Pig that recover porcine reproduction and respiratory syndrome virus infection develop cytotoxic CD4+CD8+ and CD4+CD8− T-cells that kill virus infected cells. PloS ONE. (2018) 13:0203482 10.1371/journal.pone.0203482 PubMed DOI PMC

Martinez-Lobo FJ, de Lome LC, Diez-Fuertes F, Segales J, Garcia-Artiga C, Simarro I, et al. Safety of reproductive and respire syndrome modified live virus (MLV) vaccine strains in a young pig infection model. Vet Res. (2013) 44:115 10.1186/1297-9716-44-115 PubMed DOI PMC

Shi M, Lam TTY, Hon CH, Hui RK, Faaberg KS, Vennblom T, et al. . Molecular epidemiology of PRRSV: a phylogenetic perspective. Vet Res. (2010) 154:7–17. 10.1016/j.virusres.2010.08.014 PubMed DOI

Wang X, Yang X, Rong Z, Zhou L, Ge X, Guo X. Genomic characterization and pathogenicity of a strain of type 1 porcine reproductive and respiratory syndrome virus. Virus Res. (2016) 225:40–9. 10.1016/j.virusres.2016.09.006 PubMed DOI

Heller P, Schagemann G, Schroder C, Stampa E, Ohlinger V, Wendt M. Elimination of PRRS virus (EU-type) from farrow-to finish breeding farm by vaccination with Ingel-vac ® PRRS MLV under unfavourable conditions. Praktische Tierarzt. (2011) 92:416–20.

Zhao Z, Qin Y, Lai Z, Peng L, Cai X, Wang L, et al. . Microbial ecology of swine farms and PRRS vaccine vaccination strategies. Vet Microbiol. (2012) 155:247–56. 10.1016/j.vetmic.2011.09.028 PubMed DOI

Werdeling F, Mues G, Offenberg S, Zantz S, Fiebig K. Development and control of an acute PRRS field virus infection in an endemic PRRS breeding herd after vaccination with modified live vaccine. Praktische Tierarzt. (2012) 93:722–7.

Cheah ZH, Ooi PT, Phang LY, Chua V, Low SE, Cheah HC, et al. Different porcine reproductive and respiratory syndrome (PRRS) vaccine regimes and its effect on pig immunity status at South Asia pig farms. Trop Biomed. (2017) 34:388–95. PubMed

Jeong J, Kim S, Park KH, Kang I, Park SJ, Park CH, et al. Evaluation of the effect of a porcine reproductive and respiratory syndrome (PRRS) modified-live virus vaccine on sow reproductive performance in endemic PRRS farm. Vet Microbiol. (2017) 208:47–52. 10.1016/j.vetmic.2017.07.016 PubMed DOI

Toman M, Celer V, Smola J. Successful elimination of PRRS virus from an infected farrow-to-finish herd by vaccination. Vet Med Czech. (2017) 62:553–8. 10.17221/68/2017-VETMED DOI

Modified live vaccine strains of porcine reproductive and respiratory syndrome virus cause immune system dysregulation similar to wild strains